Nov 1, 2024 · soon after vyvanse’s patent expired in 2023, applications for generic formulations of lisdexamfetamine dimesylate started flowing into the fda.
The Untold Story Behind The Vyvanse Leak
Nov 1, 2024 · soon after vyvanse’s patent expired in 2023, applications for generic formulations of lisdexamfetamine dimesylate started flowing into the fda....